News|Articles|July 3, 2026
9 Cardiology Headlines You Missed in Q2 2026
Author(s)Ryan Livingston
Fact checked by: Abigail Brooks, MA
Catch up on key FDA approvals, major trial updates, and critical clinician insights from the last 3 months.
Advertisement
Advertisement
The second quarter of 2026 saw an influx of major cardiology news, with the US Food and Drug Administration (FDA) approving some significantly beneficial drugs and a slew of conferences providing key clinician insights into ongoing and completed trials. Everything from heart failure to cardiomyopathy was highlighted over the last 3 months – in fact, an entirely new form of the former was established formally by the Heart Failure Society of America (HFSA) in May.
Advertisement
Advertisement